See also this year's filing and all EDGAR filings for this company.
PDF Report 0001358403_2020_Bellicum_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001358403, Bellicum Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 111,854,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,529,000 |
| 3 | remainder_Assets | 1,867,000 |
| 4 | LiabilitiesCurrent | 94,418,000 |
| 5 | LiabilitiesNoncurrent | 25,717,000 |
| 6 | remainder_Liabilities | 864,000 |
| 7 | CostOfGoodsAndServicesSold | 425,602 |
| 8 | SellingGeneralAndAdministrativeExpense | 34,937,582 |
| 9 | ResearchAndDevelopmentExpense | 57,341,896 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 37,234,096 |
| 12 | remainder_NetIncome | -2,673,709 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 116,250,000 |
| 1 | Liabilities | 120,999,000 |
| 2 | Expenses | 92,705,080 |
| 3 | Revenues | 37,234,096 |
| 4 | StockholdersEquity | -4,749,000 |
| 5 | NetIncome | -58,144,693 |
| 6 | ComprehensiveNetIncome | -58,144,693 |
| 7 | BaseVar | 184,930,942 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.577 |
| 9 | EconomicCapitalRatio | 1.37 |
Edgar->Model Mapping
Feature Distribution
Change over Time
